TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
22/07/2026
Voltar para busca
Dado oficial do USPTO
SEMA4
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Snapshot rápido
SEMA4
ST13
US500000086983080Classe
1, 5, 35, 42, 44
Pedido
86983080
Registro
5330559
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
71
Atualização mais recente
23/07/2026
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
1, 5, 35, 42, 44
Data de depósito
11/06/2015
Data de registro
07/11/2017
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
30/01/2025
Última transação
23/07/2026
Escritório responsável
United States Patent and Trademark Office
Código da situação
704
Cadastro oficial
Principal Register
Fundamento do pedido
Intent to use
Primeiro uso
01/05/2017
Primeiro uso no comércio
01/05/2017
Código do desenho
4
Tipo de titular
03
Localização do titular
Stamford, CT, US
Examinador
FALK, JONATHAN ROBERT
Localização atual
PUBLICATION AND ISSUE SECTION
Titulares e representantes
Titulares
SEMA4 OPCO, INC.
MOUNT SINAI GENOMICS, INC.
Icahn School of Medicine at Mount Sinai
Representantes
Lisa C. Pavento Meunier Carlin & Curfman LLC
Classificação técnica
Classes Nice
Classe 1Classe 5Classe 35Classe 42Classe 44
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 1
Kits containing chemical and biochemical assays and reagents for scientific research use; nucleic acid and protein isolation kits comprised primarily of assays and reagents for use in epigenetic research and analysis; none of the aforementioned involve the use or study of semaphorins
Classe 5
Pharmaceutical preparations and substances for the prevention and treatment of disorders and diseasescancer and Mendelian disorders; test kits consisting of medical diagnostic reagents and assays for testing in the field of the prevention and treatment of disorders and diseases; none of the aforementioned involve the use or study of semaphorins
Classe 35
Business consulting and business information services regarding precision health diagnosis and personalized treatment; business consulting and business information services regarding the analysis and packaging of health data; providing business informationcommercial corporate and statistical information provided on-line from a computer database or the Internet; statistical analysis and reporting services for business purposes; business consulting and business information services regarding the identification of drug targets; business consulting and business information services regarding bioinformatic analysis; population health management
Classe 42
Medical and scientific research in the field of biologic testing and interpretationdiagnosistreatmenthealth maintenance; bioinformatics interpretation of health data; medical and scientific research in the field of ancestry analysis for scientific research purposes; compiling data for research purposes in the field of medical science and medical consultancy for use in connection with diagnostic testing; analysis and screening of nucleic acids for scientific research purposes; genome mapping for scientific purposes; providing information in the field of disease classification for use in connection with diagnostic testing ; development of scientific research and technology for purposes of disease diagnosispreventative health carehealth monitoringpersonalized treatment; providing a website featuring non-downloadable software for patient access to health care services and health information; providing a website featuring non-downloadable software for patient access to diagnosistreatmenthealth maintenance information; providing a website featuring non-downloadable software for accessingviewinginteracting with and downloading personal health recordsdiagnosestreatment planshealth monitoring information; scientific and medical researchidentifying drug targets; scientific research relating to population health management; none of the aforementioned involve the use or study of semaphorins
Classe 44
Diagnostic services in the field of medicine; medical testing for diagnosis of diseases and treatment purposes ; bioinformatics analysis for medical diagnostic and personalized treatment purposes; biochemical testing for ancestry analysis and personalized diagnostics and treatments; nucleic acid analysis and screening for medical diagnostic and treatment purposes; DNA analysis and screening for medical diagnostic and treatment purposes; consulting services in the field of biological sequence and bioinformatic processing for medical diagnosis and treatment purposes; health care servicesleveraging health monitoring and data science to provide optimal health and disease prevention to patients; creating personalized preventative health-care programs and disease management programs; providing an online resource center featuring personalized health information based on health information and diagnostics; medical testingidentifying drug targets for diagnostic or treatment purposes; none of the aforementioned involve the use or study of semaphorins
Publicações
Histórico de despachos e eventos da marca no USPTO.
71 publicações encontradas
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
22/07/2026
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
22/07/2026
WOAG
WITHDRAWAL OF ATTORNEY GRANTED
01/06/2026
WOAR
TEAS WITHDRAWAL OF ATTORNEY RECEIVED
01/06/2026
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
01/05/2025
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
01/05/2025
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
01/05/2025
NAS8
NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
30/01/2025
8.PR
REGISTERED - PARTIAL SEC. 8 (6-YR) ACCEPTED
30/01/2025
PRAN
POST REGISTRATION ACTION MAILED NO RESPONSE REQUIRED
30/01/2025
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
30/01/2025
EWAF
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
28/10/2024
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
28/10/2024
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
28/10/2024
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
28/10/2024
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
28/10/2024
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
28/10/2024
ES8R
TEAS SECTION 8 RECEIVED
07/05/2024
ASCK
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
08/11/2023
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
07/11/2022
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
10/05/2022
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
10/05/2022
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
10/05/2022
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
04/08/2021
COC.
CORRECTION UNDER SECTION 7 - PROCESSED
07/05/2018
EROP
TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
07/05/2018
PRAM
POST REGISTRATION ACTION MAILED - SEC. 7
27/12/2017
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
27/12/2017
FAXX
FAX RECEIVED
27/11/2017
ES7R
TEAS SECTION 7 REQUEST RECEIVED
20/11/2017
R.PR
REGISTERED-PRINCIPAL REGISTER
07/11/2017
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
30/09/2017
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
29/09/2017
SUPC
STATEMENT OF USE PROCESSING COMPLETE
13/09/2017
DPCC
DIVISIONAL PROCESSING COMPLETE
13/09/2017
IUAF
USE AMENDMENT FILED
11/09/2017
DRRR
DIVISIONAL REQUEST RECEIVED
11/09/2017
ERTD
TEAS REQUEST TO DIVIDE RECEIVED
11/09/2017
EISU
TEAS STATEMENT OF USE RECEIVED
11/09/2017
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
30/08/2017
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
17/03/2017
EX2G
SOU EXTENSION 2 GRANTED
15/03/2017
EXT2
SOU EXTENSION 2 FILED
15/03/2017
EEXT
SOU TEAS EXTENSION RECEIVED
15/03/2017
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
30/11/2016
EX1G
SOU EXTENSION 1 GRANTED
29/11/2016
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
28/11/2016
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
20/10/2016
NREV
NOTICE OF REVIVAL - E-MAILED
20/10/2016
TPEX
SOU EXTENSION RECEIVED WITH TEAS PETITION
20/10/2016
PETG
PETITION TO REVIVE-GRANTED
20/10/2016
PROA
TEAS PETITION TO REVIVE RECEIVED
20/10/2016
MAB6
ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
17/10/2016
ABN6
ABANDONMENT - NO USE STATEMENT FILED
17/10/2016
EXT1
SOU EXTENSION 1 FILED
15/09/2016
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
15/03/2016
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
19/01/2016
PUBO
PUBLISHED FOR OPPOSITION
19/01/2016
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
30/12/2015
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
15/12/2015
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
10/12/2015
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
08/12/2015
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
08/12/2015
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
16/07/2015
GNRT
NON-FINAL ACTION E-MAILED
16/07/2015
CNRT
NON-FINAL ACTION WRITTEN
16/07/2015
DOCK
ASSIGNED TO EXAMINER
11/07/2015
MPMK
NOTICE OF PSEUDO MARK E-MAILED
16/06/2015
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
15/06/2015
NWAP
NEW APPLICATION ENTERED
15/06/2015
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace SEMA4 ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.